5 posts tagged with prostatecancer.
Displaying 1 through 5 of 5. Subscribe:

Nothing is straightforward in the cancer world.

More Men With Early Prostate Cancer Choosing to Avoid Treatment [Gina Kolata, New York Times] [more inside]
posted by joseph conrad is fully awesome on May 24, 2016 - 28 comments

Starbucks better than Hospital.

Men who drink the most coffee have a 60% lower risk of developing lethal prostate cancer. 'Even drinking one to three cups of coffee per day was associated with a 30% lower risk of lethal prostate cancer.' But is that down to perhaps coffee drinkers having healthier habits? No: 'Coffee drinkers were more likely to smoke and less likely to exercise, behaviors that may increase advanced prostate cancer risk. These and other lifestyle factors were controlled for in the study and coffee still was associated with a lower risk.' [more inside]
posted by VikingSword on May 18, 2011 - 58 comments

Gotta die sometime and from something.

What Is Good for the Heart May Not Be Good for the Prostate, Study Suggests. In a major study that appears to overturn a lot of previous research, the largest and most authoritative study ever to examine the association of dietary fats and prostate cancer risk has found an inverse association in the effect of Omega-3 fatty acids in heart disease and in prostate cancer. A lot of recent conventional wisdom has been upended, with the role of all fatty acids undergoing substantial revisions in our understanding. [more inside]
posted by VikingSword on Apr 25, 2011 - 120 comments

"Don't come in, I'm... doing my utmost in the fight against cancer!"

Masturbation cuts cancer risk! That is all.
posted by crossoverman on Nov 5, 2010 - 67 comments

The Right to a Trial?

The fight over an experimental cancer therapy gets ugly. The FDA's decision to delay approval of Provenge, an experimental therapy for advanced prostate cancer, has incensed patients and advocacy groups, who have launched a sophisticated lobbying effort calling for the drug's approval and questioning the motives of critics. Of course, investors in Dendreon, the creators of Provenge, have a strong financial interest in seeing Provenge approved. The New Yorker covers the complicated issues surrounding patient access to experimental therapies in this story.
posted by myeviltwin on Jul 6, 2007 - 28 comments

Page: 1